Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ... Cell Death & Differentiation 9 (3), 246-251, 2002 | 264 | 2002 |
Quality assessment of genetic markers used for therapy stratification IM Ambros, J Benard, M Boavida, N Bown, H Caron, V Combaret, ... Journal of clinical oncology 21 (11), 2077-2084, 2003 | 142 | 2003 |
MYCN On cogene Amplification in Neuroblastom a Is Associated VVith VVorse Prognosis, Except in Stage 4s: The Italian Experience VVith 295 Children GP Tonini, L Boni, A Pession, D Rogers Journal of clinical oncology 15 (1), 85-93, 1997 | 138 | 1997 |
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors M Łastowska, C Cullinane, S Variend, S Cotterill, N Bown, S O’Neill, ... Journal of clinical oncology 19 (12), 3080-3090, 2001 | 135 | 2001 |
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative … G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri, H Rubie, ... British journal of cancer 105 (12), 1940-1948, 2011 | 108 | 2011 |
Neuroblastoma in adolescents: the Italian experience M Conte, S Parodi, B De Bernardi, C Milanaccio, K Mazzocco, P Angelini, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 108 | 2006 |
Genomic amplifications and distal 6q loss: novel markers for poor survival in high-risk neuroblastoma patients P Depuydt, V Boeva, TD Hocking, R Cannoodt, IM Ambros, PF Ambros, ... JNCI: Journal of the National Cancer Institute 110 (10), 1084-1093, 2018 | 93 | 2018 |
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases C Gambini, M Conte, G Bernini, P Angelini, A Pession, P Paolucci, ... Virchows Archiv 442, 555-562, 2003 | 87 | 2003 |
A multilocus technique for risk evaluation of patients with neuroblastoma IM Ambros, B Brunner, G Aigner, C Bedwell, K Beiske, J Bénard, N Bown, ... Clinical Cancer Research 17 (4), 792-804, 2011 | 60 | 2011 |
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins F Morandi, P Scaruffi, F Gallo, S Stigliani, S Moretti, S Bonassi, C Gambini, ... PloS one 7 (1), e29922, 2012 | 58 | 2012 |
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study AP Berbegall, D Bogen, U Pötschger, K Beiske, N Bown, V Combaret, ... British journal of cancer 118 (11), 1502-1512, 2018 | 52 | 2018 |
Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: a proof of concept SIOPEN study‖ M Morini, D Cangelosi, D Segalerba, D Marimpietri, F Raggi, A Castellano, ... Cancers 11 (10), 1476, 2019 | 50 | 2019 |
Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma P Origone, R Defferrari, K Mazzocco, CL Cunsolo, BD Bernardi, GP Tonini American Journal of Medical Genetics Part A 118 (4), 309-313, 2003 | 49 | 2003 |
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors A Garaventa, L Boni, MSL Piccolo, GP Tonini, C Gambini, A Mancini, ... Annals of Oncology 13 (6), 956-964, 2002 | 48 | 2002 |
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN … R Defferrari, K Mazzocco, IM Ambros, PF Ambros, C Bedwell, K Beiske, ... British journal of cancer 112 (2), 290-295, 2015 | 46 | 2015 |
Real-Time Quantitative PCR for the Measurement of MYCN Amplification in Human Neuroblastoma with the TaqMan Detection System CC Raggi, ML Bagnoni, GP Tonini, M Maggi, G Vona, P Pinzani, ... Clinical chemistry 45 (11), 1918-1924, 1999 | 43 | 1999 |
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization P Scaruffi, S Coco, F Cifuentes, D Albino, M Nair, R Defferrari, ... Cancer genetics and cytogenetics 177 (1), 20-29, 2007 | 42 | 2007 |
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR … A Bellini, U Pötschger, V Bernard, E Lapouble, S Baulande, PF Ambros, ... Journal of Clinical Oncology 39 (30), 3377-3390, 2021 | 39 | 2021 |
Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells S Coco, R Defferrari, P Scaruffi, A Cavazzana, C Di Cristofano, L Longo, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 36 | 2005 |
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease MR Esposito, A Binatti, M Pantile, A Coppe, K Mazzocco, L Longo, ... International journal of cancer 143 (10), 2525-2536, 2018 | 32 | 2018 |